Home/Filings/4/0001140361-23-026721
4//SEC Filing

Franchi Jean M. 4

Accession 0001140361-23-026721

CIK 0001439725other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 6:22 PM ET

Size

6.3 KB

Accession

0001140361-23-026721

Insider Transaction Report

Form 4
Period: 2023-05-23
Transactions
  • Award

    Restricted Stock Units

    2023-05-23+40,42240,422 total
    Common Stock (40,422 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
  • [F3]Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
  • [F4]The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

Documents

1 file

Issuer

BIODESIX INC

CIK 0001439725

Entity typeother

Related Parties

1
  • filerCIK 0001653053

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 6:22 PM ET
Size
6.3 KB